Cochrane Abstracts
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Inhaled Short Acting Beta2-agonist Use in Chronic Asthma: Regular Versus as Needed Treatment: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review. Accessed 07 March 2021.
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review. Accessed March 7, 2021.
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review
Inhaled Short Acting Beta2-agonist Use in Chronic Asthma: Regular Versus as Needed Treatment: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 March 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment: Cochrane systematic review
ID - 431753
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431753/all/Inhaled_short_acting_beta2_agonist_use_in_chronic_asthma:_regular_versus_as_needed_treatment:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
